# Microbiome in Colorectal Cancer Onset and Progression

> **NCT05368688** · — · TERMINATED · sponsor: **Viome** · enrollment: 63 (actual)

## Conditions studied

- Colorectal Cancer
- Tumor
- CRC
- GI Cancer
- Gastrointestinal Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05368688
- **Lead sponsor:** Viome
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2022-06-30
- **Primary completion:** 2022-12-22
- **Final completion:** 2022-12-22
- **Target enrollment:** 63 (ACTUAL)
- **Why stopped:** Recruitment rate was too low to continue the study.
- **Last updated:** 2022-12-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05368688

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05368688, "Microbiome in Colorectal Cancer Onset and Progression". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05368688. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*